Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Click here - LXG too late yet again
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(45)
•••
Comment by EduardoSanchezon Mar 13, 2020 1:57pm
92 Views
Post# 30804968

RE:Click here - LXG too late yet again

RE:Click here - LXG too late yet again

Lexagene is a pre revenue company that has just switched from R&D mode. They have 29 employees. They are ramping up for commercialization and are creating a very complicated technology with microfluidics, robotics, software.... Roche is a $250 billion company. The Roche solution is still a central lab/hospital solution and not a true point of care solution and takes 3.5 hours to run. Currently Roche is probably the best reactive solution but Lex is creating a proactive solution with point care solution and the open access feature that eliminates the need for custom embedded assays. 

They are currently working with the CDC and are looking to start a beta test program to research Covid-19 within the upcoming weeks. This is big news. Along with the recent 40% cost reduction for the LX Analyzer. Lots of news coming! This outbreak is just starting, 2nd waves are usually worse, Lex is ramping to address the 2nd wave 
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities